Contact Us: 01282 426380
KM Financial Solutions | U.S. FDA clears Israeli startup Sight Diagnostics’ finger prick blood test
57274
post-template-default,single,single-post,postid-57274,single-format-standard,qode-quick-links-1.0,ajax_fade,page_not_loaded,,qode_grid_1300,footer_responsive_adv,hide_top_bar_on_mobile_header,qode-child-theme-ver-1.0.0,qode-theme-ver-11.2,qode-theme-bridge,wpb-js-composer js-comp-ver-5.2.1,vc_responsive
 

U.S. FDA clears Israeli startup Sight Diagnostics’ finger prick blood test

03 Dec U.S. FDA clears Israeli startup Sight Diagnostics’ finger prick blood test

Posted at 17:00h in News by
0 Likes
Israeli startup Sight Diagnostics said on
Wednesday the U.S. Food and Drug Administration had cleared its
device that can process results for the most commonly needed
blood test in about ten minutes.

No Comments

Sorry, the comment form is closed at this time.